Back to Search
Start Over
An audit of the management of childhood-onset growth hormone deficiency during young adulthood in Scotland
- Publication Year :
- 2016
- Publisher :
- BioMed Central, 2016.
-
Abstract
- Background\ud Adolescents with childhood onset growth hormone deficiency (CO-GHD) require re-evaluation of their growth hormone (GH) axis on attainment of final height to determine eligibility for adult GH therapy (rhGH).\ud \ud Aim:\ud Retrospective multicentre review of management of young adults with CO-GHD in four paediatric centres in Scotland during transition.\ud \ud Patients:\ud Medical records of 130 eligible CO-GHD adolescents (78 males), who attained final height between 2005 and 2013 were reviewed. Median (range) age at initial diagnosis of CO-GHD was 10.7 years (0.1–16.4) with a stimulated GH peak of 2.3 μg/l (0.1–6.5). Median age at initiation of rhGH was 10.8 years (0.4–17.0).\ud \ud Results:\ud Of the 130 CO-GHD adolescents, 74/130(57 %) had GH axis re-evaluation by stimulation tests /IGF-1 measurements. Of those, 61/74 (82 %) remained GHD with 51/74 (69 %) restarting adult rhGH. Predictors of persistent GHD included an organic hypothalamic-pituitary disorder and multiple pituitary hormone deficiencies (MPHD). Of the remaining 56/130 (43 %) patients who were not re-tested, 34/56 (61 %) were transferred to adult services on rhGH without biochemical retesting and 32/34 of these had MPHD. The proportion of adults who were offered rhGH without biochemical re-testing in the four centres ranged between 10 and 50 % of their total cohort.\ud \ud Conclusions:\ud A substantial proportion of adults with CO-GHD remain GHD, particularly those with MPHD and most opt for treatment with rhGH. Despite clinical guidelines, there is significant variation in the management of CO-GHD in young adulthood across Scotland.
Details
- Language :
- English
- ISSN :
- 16879856
- Database :
- OpenAIRE
- Accession number :
- edsair.core.ac.uk....f28789cd6bbca41bf1ed28f8f80de1ba